Change in creatinine clearance over time following upper abdominal irradiation: A dose-Volume histogram multivariate analysis

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 34, Issue 1, 2011, Pages 53-57

  Diavolitsis, Virginia M ^a   Rademaker, Alfred ^a   Boyle, John ^a   Kang, Zhuang ^a   Kiel, Krystyna ^a   Mulcahy, Mary ^a   Small, William ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

complications radiotherapy; creatinine clearance; late renal toxicity; normal tissue tolerance; three dimensional treatment planning

Indexed keywords

ANTIHYPERTENSIVE AGENT; CREATININE; FLUOROURACIL; GEMCITABINE; PLATINUM COMPLEX;

ABDOMINAL RADIOGRAPHY; ADOLESCENT; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CREATININE CLEARANCE; DIABETES MELLITUS; ESOPHAGUS CANCER; FEMALE; GASTROESOPHAGUS JUNCTION CANCER; HEPATOBILIARY SYSTEM CANCER; HISTOGRAM; HUMAN; HYPERTENSION; KIDNEY FUNCTION; KIDNEY SIZE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEPHROTOXICITY; OUTCOME ASSESSMENT; PANCREAS CANCER; RADIATION DOSE; RADIATION DOSE FRACTIONATION; STOMACH CANCER; UPPER GASTROINTESTINAL TRACT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CREATININE; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL NEOPLASMS; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIATION INJURIES; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79951673626     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3181d27080     Document Type: Article

References (17)

1. Dewit L, Anninga JK, Hoefnagel CA, et al. Radiation injury in the human kidney: a prospective analysis using specific scintigraphic and biochemical endpoints. Int J Radiat Oncol Biol Phys. 1990;19:977-983. (Pubitemid 20345169)
2. Fajardo LF. Morphology of radiation effects on normal tissues. In: Perez C, Brady L, eds. Principles and Practice of Radiation Oncology. 2nd ed. Philadelphia, PA: JB Lippincott; 1992:114-123.
3. Cassady JR. Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys. 1995;31:1249-1256.
4. Turesson I. The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships. Radiother Oncol. 1989;15:217-226. (Pubitemid 19193913)
5. Verheij M, Dewit LG, Valdes Olmos RA, et al. Evidence for a renovascular component in hypertensive patients with late radiation nephropathy. Int J Radiat Oncol Biol Phys. 1994;30:677-683. (Pubitemid 24304480)
6. Jansen EP, Saunders MP, Boot H. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys. 2007;67:781-785. (Pubitemid 46215865)
7. Willett CG, Tepper JE, Orlow EL, et al. Renal complications secondary to radiation treatment of upper abdominal malignancies. Int J Radiat Oncol Biol Phys. 1986;12:1601-1604. (Pubitemid 17175245)
8. Kost S, Dorr W, Keinert K, et al. Effect of dose and dose-distribution in damage to the kidney following abdominal radiotherapy. Int J Radiat Oncol Biol Phys. 2002;8:695-702. (Pubitemid 34971773)
9. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic radiation. Int J Radiat Oncol Biol Phys. 1991;21:109-122.
10. Armstrong JG, Zelefsky MJ, Leibel SA, et al. Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. Ann Oncol. 1995;6:693-697.
11. Graham MV, Purdy JA, Emami B, et al. Clinical dose volume histogram analysis for pneumonitis after 3D treatment for nonsmall cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 1999;45:323-329. (Pubitemid 29408545)
12. Hernando ML, Marks LB, Bentel GC, et al. Radiation induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys. 2001;51:650-659.
13. Claude L, Perol D, Ginestet C, et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol. 2004;71: 175-181. (Pubitemid 38521186)
14. Wang S, Liao Z, Wei X, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2006;66:1399-1407.
15. Yom SS, Liao Z, Liu HH, et al. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2007;68:94-102. (Pubitemid 46589835)
16. Wang S, Liao Z, Vaporciyan AA, et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradio-therapy followed by surgery. Int J Radiat Oncol Biol Phys. 2006;64:692-699. (Pubitemid 43183562)
17. Schallenkamp JM, Miller RC, Brinkmann DH, et al. Incidence of radiation pneumonitis after thoracic irradiation: dose-volume correlates. Int J Radiat Oncol Biol Phys. 2007;67:410-416. (Pubitemid 46108327)